These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4275974)

  • 21. Increase of brain tryptophan caused by drugs which stimulate serotonin synthesis.
    Tagliamonte A; Tagliamonte P; Perez-Cruet J; Gessa GL
    Nat New Biol; 1971 Jan; 229(4):125-6. PubMed ID: 4326812
    [No Abstract]   [Full Text] [Related]  

  • 22. Difference in oral effectiveness of two tyrosine hydroxylase inhibitors.
    Johnson GA; Kim EG; Veldkamp W; Russell R
    Biochem Pharmacol; 1967 Feb; 16(2):401-3. PubMed ID: 6029921
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanism of the protective effect of reserpine on aggregated mice treated with (+)-amphetamine.
    Menon MK; Dandiya PC
    J Pharm Pharmacol; 1967 Sep; 19(9):596-602. PubMed ID: 4383144
    [No Abstract]   [Full Text] [Related]  

  • 24. Ultrastructural evidence for the localization of an indolealkylamine in supra-ependymal nerves from combined cytochemistry and pharmacology.
    Richards JG; Tranzer JP
    Experientia; 1974 Mar; 30(3):287-9. PubMed ID: 4274761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological analysis of the neurotransmitter mechanisms regulating phenylethanolamine N-methyltransferase in the adrenal gland.
    Lima L; Sourkes TL
    Biochem Pharmacol; 1986 Nov; 35(22):3965-9. PubMed ID: 2946301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of catecholamines for the interaction between reserpine and desipramine on body temperature in rats.
    Jori A; Bernardi D
    Pharmacology; 1970; 4(4):235-41. PubMed ID: 5489997
    [No Abstract]   [Full Text] [Related]  

  • 27. The relation between monoamines in brain and the anticonvulsant action of inhibition of carbonic anhydrase.
    Gray WD; Rauh CE
    J Pharmacol Exp Ther; 1971 Apr; 177(1):206-18. PubMed ID: 4254846
    [No Abstract]   [Full Text] [Related]  

  • 28. A role for central serotonergic systems in the pattern and intensity of the convulsive response of rats to electroshock.
    Buterbaugh GG
    Neuropharmacology; 1977 Oct; 16(10):707-9. PubMed ID: 145548
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of brain amines in learning associated with "amphetamine-state".
    Roffman M; Lal H
    Psychopharmacologia; 1972; 25(3):195-204. PubMed ID: 4402958
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine and 5,7-dihydroxytryptamine on the hippocampal kindling effect in rats.
    Araki H; Aihara H; Watanabe S; Yamamoto T; Ueki S
    Jpn J Pharmacol; 1983 Dec; 33(6):1177-82. PubMed ID: 6230476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation between seizure susceptibility and brain catecholamine levels. An experimental study using a kindling preparation].
    Sato M; Nakashima T; Mitsunobu K; Otsuki S
    No To Shinkei; 1976 May; 28(5):471-7. PubMed ID: 140696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the aggressiveness-stereotypy complex induced in mice by amphetamine or D,L-dopa. II.
    Roliński Z
    Pol J Pharmacol Pharm; 1974; 26(3):369-78. PubMed ID: 4277363
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings: Amine depletion as an experimental approach to the aminergic hypothesis.
    Mendels J
    Psychopharmacol Bull; 1974 Oct; 10(4):54-6. PubMed ID: 4279415
    [No Abstract]   [Full Text] [Related]  

  • 34. Monoaminergic control of episodic growth hormone secretion in the rat: effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine, and haloperidol.
    Edén S; Bolle P; Modigh K
    Endocrinology; 1979 Aug; 105(2):523-9. PubMed ID: 156637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some effects of dl-4-(2-hydroxy-3-isopropylaminopropoxy) indole (LB46) on brain monoamines and their precursors.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):79-93. PubMed ID: 5072194
    [No Abstract]   [Full Text] [Related]  

  • 36. Serotonergic inhibition of catecholamine-induced behavioral arousal.
    Mabry PD; Campbell BA
    Brain Res; 1973 Jan; 49(2):381-91. PubMed ID: 4269051
    [No Abstract]   [Full Text] [Related]  

  • 37. The occurrence of tryptamine in rat brain and its pharmacological manipulation.
    Horn AS; Snodgrass SR
    Br J Pharmacol; 1973 Mar; 47(3):646P. PubMed ID: 4147196
    [No Abstract]   [Full Text] [Related]  

  • 38. The possible role of brain monoamines in the acute toxicity of digitoxigenin.
    Buterbaugh GG; Spratt JL
    J Pharmacol Exp Ther; 1970 Oct; 175(1):121-30. PubMed ID: 4394300
    [No Abstract]   [Full Text] [Related]  

  • 39. The differential neurochemical bases of the behaviours elicited by serotonergic agents and by the combination of a monoamine oxidase inhibitor and L-DOPA.
    Deakin JF; Dashwood MR
    Neuropharmacology; 1981 Feb; 20(2):123-30. PubMed ID: 6451815
    [No Abstract]   [Full Text] [Related]  

  • 40. Postnatal elevation of brain tyrosine hydroxylase activity, without concurrent increases in steady-state catecholamine levels, resulting from dl-alpha-methylparatyrosine administration during embryonic development.
    Lydiard RB; Fossom LH; Sparber SB
    J Pharmacol Exp Ther; 1975 Jul; 194(1):27-36. PubMed ID: 239220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.